Ep 12: The Age of Inflammation… The Real Silent Killer? okładka

Ep 12: The Age of Inflammation… The Real Silent Killer?

Ep 12: The Age of Inflammation… The Real Silent Killer?

Słuchaj bezpłatnie, bez subskrypcji

Zobacz szczegóły

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
O tym tytule

What deserves a closer look when you’re training, eating carefully and still don’t feel your best? Frank Fontana shares the questions he is asking about inflammation, recovery and life after 50—from food and training to the conversations worth having with a qualified clinician.


This episode includes personal experiences and opinions, not a diagnosis or treatment plan. Puffiness, bloating and weight changes do not by themselves establish chronic inflammation. Do not start, stop or change medication, peptides, supplements or an elimination diet based on this discussion; consult your licensed clinician. Retatrutide is investigational and is not FDA-approved; FDA states it cannot lawfully be compounded. Benefits and approvals of other GLP-1 medicines should not be assumed to apply to it.


CHAPTERS

00:00 Welcome to PRIME50

02:11 Personal experience, medical disclaimer and food questions

04:38 Diet changes and recovery

07:02 Training load, hydration and bloating

09:28 Frank’s experience with supplements and experimental compounds

11:51 Medication discussion and questions for a clinician

14:15 Environmental concerns and mold

16:37 Inflammation, health and elimination diets

19:07 Abdominal fat and metabolic health

21:35 Symptoms and laboratory discussions

23:56 What tests can—and cannot—tell you

27:19 Supplements and experimental approaches

29:40 Measuring progress and restoring balance

31:39 Closing thoughts and where to follow PRIME50


Subscribe to PRIME50 for Frank’s journey through purpose, reinvention and optimization after 50.


FDA reference: https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

adbl_web_anon_alc_button_suppression_t1
Brak recenzji